A mass-spectral library suggestion was not the final drug identity in a reported MDPHP death. General unknown screening returned a 72% match to a differently named cathinone, while subsequent LC–MS/MS identified MDPHP. The score described the screening comparison; it was not a validated 72% probability that the suggested compound was present.
The case required testing beyond the expected drug
Croce and colleagues described a 30-year-old man found dead at home with a history of cocaine use. The report estimated a postmortem interval of three to four hours; being last seen alive 24 hours earlier was a separate observation, not the same interval. Autopsy findings included congestion and pulmonary edema without a uniquely diagnostic drug-poisoning lesion.
Central and peripheral blood, urine, gastric contents, separate right and left vitreous samples, and hair were collected. Common drugs of abuse were not detected in the liquid specimens by the reported GC–MS investigation. That did not establish the absence of every psychoactive substance.
What the screening library suggested
The general unknown screening result suggested “4′-methyl-α-pyrrolidinohexanophenone,” with a reported 72% likelihood against the SWGDRUG library used by the investigators. This was a candidate generated by a screening workflow, not an independently confirmed diagnosis.
A library-search output depends on the reference spectra and comparison method. The case supplied no validation converting that particular numerical score into the chance of correct identification. Repeating it as a certainty about the compound would misstate the evidence.
What established the reported MDPHP result?
The investigators used an MDPHP reference standard and a targeted LC–MS/MS procedure. The method reported an MDPHP precursor ion at m/z 290, transitions to m/z 135 and 140, and retention time of 15.6 minutes. Identification and quantification therefore drew on additional analytical evidence beyond the initial library suggestion.
For liquid specimens, the paper reported a quantification limit of 0.5 ng/mL, recovery of 78.8% and ion suppression of −20.4%. These are the performance figures described in this case report; they do not establish that every possible matrix or interfering compound was independently evaluated within the report.
MDPHP was measured at 1,639.99 ng/mL in central blood and 1,601.90 ng/mL in peripheral blood. The exact peripheral anatomical collection site was not specified. Urine, gastric contents and both vitreous specimens also contained MDPHP.
A quantitative finding still required causal interpretation
The authors attributed the death probably to a lethal MDPHP exposure, integrating the high concentrations, examination and available circumstances. Their comparison with previously published cases was descriptive casework, not a statistical experiment establishing a lethal threshold.
They could not determine a precise intake time or exclude previous or repeated consumption. Hair also contained other drugs, which documented a different exposure history rather than proving all those substances were active at death.
What to preserve when reading a laboratory report
Separate the initial candidate, the confirming analytical evidence and the final quantitative result. Record the library version, method scope, specimen and units. A negative conventional screen and a positive broader investigation can coexist without either result being contradictory.
Neither the library score nor MDPHP detection alone establishes impairment or cause of death. For another identification problem, see why accurate mass does not resolve every drug identity.
Primary source
Croce EB, Dimitrova A, Di Milia MG, et al. Postmortem distribution of MDPHP in a fatal intoxication case. Journal of Analytical Toxicology. 2025;49:137–141. doi:10.1093/jat/bkae092.
Leave a Reply